Product
Tumor-infiltrating lymphocytes
1 clinical trial
2 indications
Indication
Breast CancerIndication
Lung CancerClinical trial
Phase I Clinical Trial to Evaluate the Safety and Tolerability of NEOG-100 in Patients With Advanced Breast Cancer and Lung CancerStatus: Not yet recruiting, Estimated PCD: 2025-09-01